Literature DB >> 10915067

The senescence-accelerated mouse shows aging-related defects in cellular but not humoral immunity against influenza virus infection.

L Dong1, I Mori, M J Hossain, Y Kimura.   

Abstract

The senescence-accelerated mouse (SAM) strain P1, which has a short life span, was adopted as a murine model for an investigation of the pathogenesis of viral infection in elderly adults. After intranasal inoculation with influenza A virus, the SAM-P1 mice showed a higher rate of mortality, with prolonged virus growth in the lungs. The increased susceptibility was associated with impaired activity of both NK cells and virus-specific cytotoxic T lymphocytes. The production of interferon-gamma and interleukin-12 was significantly restrained, which suggests a partial deficiency of the T helper (Th) 1 cells. In contrast, the immunologic activity of the Th2 cells appeared to be functionally normal, judging from the release of large amounts of interleukin-4 followed by production of appropriate amounts of influenza virus-specific antibody. It is suggested that the elicitation of cellular immunity is an important and effective procedure for protecting the elderly from influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10915067     DOI: 10.1086/315727

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus.

Authors:  Xiao-Song He; Monia Draghi; Kutubuddin Mahmood; Tyson H Holmes; George W Kemble; Cornelia L Dekker; Ann M Arvin; Peter Parham; Harry B Greenberg
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

2.  Time for T?: Thoughts about the 2009 novel H1N1 influenza outbreak and the role of T cell epitopes in the next generation of influenza vaccines.

Authors:  Anne S De Groot; Elizabeth McClaine; Lenny Moise; William Martin
Journal:  Hum Vaccin       Date:  2010-02-19

3.  Senescence-accelerated Mice (SAMs) as a Model for Brain Aging and Immunosenescence.

Authors:  Atsuyoshi Shimada; Sanae Hasegawa-Ishii
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

4.  Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine.

Authors:  Wilbur H Chen; Alan S Cross; Robert Edelman; Marcelo B Sztein; William C Blackwelder; Marcela F Pasetti
Journal:  Vaccine       Date:  2011-02-23       Impact factor: 3.641

5.  Expansion of 2B4+ natural killer (NK) cells and decrease in NKp46+ NK cells in response to influenza.

Authors:  Stephanie Jost; Jeff Reardon; Eric Peterson; Danielle Poole; Ronald Bosch; Galit Alter; Marcus Altfeld
Journal:  Immunology       Date:  2011-01-07       Impact factor: 7.397

6.  Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota.

Authors:  Tetsuji Hori; Junko Kiyoshima; Kan Shida; Hisako Yasui
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

7.  Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota.

Authors:  Hisako Yasui; Junko Kiyoshima; Tetsuji Hori
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

8.  Natural killer cell development and maturation in aged mice.

Authors:  Eleni Beli; David M Duriancik; Jonathan F Clinthorne; Taehyung Lee; Sungjin Kim; Elizabeth M Gardner
Journal:  Mech Ageing Dev       Date:  2013-12-18       Impact factor: 5.432

9.  Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses.

Authors:  Golo Ahlenstiel; Maureen P Martin; Xiaojiang Gao; Mary Carrington; Barbara Rehermann
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

10.  Impaired immune responses in the lungs of aged mice following influenza infection.

Authors:  Franklin R Toapanta; Ted M Ross
Journal:  Respir Res       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.